Sorafenib Combined With Hepatectomy in Patients With Intermediate-Stage and Advanced Hepatocellular Carcinoma

Archives of Medical Science - Poland
doi 10.5114/aoms.2017.71066
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

Sorafenib Alone Versus Sorafenib Combined With Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses

Radiology
Nuclear MedicineRadiologyImaging
2013English

Addition of Local Hepatic Therapy to Sorafenib in Patients With Advanced Hepatocellular Carcinoma (Stage BCLC C)

Digestion
Gastroenterology
2014English

Attenuation of Liver Stiffness in Sorafenib-Treated Patients With Advanced Hepatocellular Carcinoma

Hepatoma Research
2017English

Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma

Journal of Liver Research, Disorders & Therapy
2017English

Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Journal of Hepatocellular Carcinoma
2015English

Angiographic Study After Hepatectomy in Patients With Hepatocellular Carcinoma

The journal of the Japanese Practical Surgeon Society
1997English

Sorafenib-Induced Acute Interstitial Pneumonia in Patients With Advanced Hepatocellular Carcinoma: Report of Three Cases

Clinical Journal of Gastroenterology
MedicineGastroenterology
2012English

A Prognostic Score for Patients With Intermediate-Stage Hepatocellular Carcinoma Treated With Transarterial Chemoembolization

PLoS ONE
Multidisciplinary
2015English

Post-Progression Survival and Progression-Free Survival in Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib

Hepatology Research
HepatologyInfectious Diseases
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy